Treatment of plague: promising alternatives to antibiotics

Andrey P Anisimov1, Kingsley K Amoako2

  • 1Laboratory for Plague Microbiology, Department of Infectious Diseases, State Research Center for Applied Microbiology and Biotechnology, 142279 Obolensk, Serpukhov District, Moscow Region, Russia.

Insights

Plague remains a serious threat, prompting research into Yersinia pestis treatments beyond antibiotics. Alternative therapies like immunotherapy and phage therapy show promise but require further clinical investigation.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health

Background:

  • Plague, caused by Yersinia pestis, is a significant global health concern, particularly with potential bioterrorism applications.
  • The septicaemic and pneumonic forms of plague are invariably fatal without prompt treatment.
  • Historical and scientific efforts have focused on effective plague treatment, leading to antibiotic-based therapies.

Purpose of the Study:

  • To review the current landscape of plague treatment strategies.
  • To explore alternative therapeutic approaches to combat Yersinia pestis infections.
  • To highlight the need for further research into novel plague treatments.

Main Methods:

  • Literature review of historical and contemporary plague treatment modalities.
  • Examination of antibiotic therapies, including tetracycline and streptomycin.
  • Investigation into alternative treatments such as immunotherapy, phage therapy, and virulence factor inhibitors.

Main Results:

  • Antibiotics are the current 'gold standard' for plague treatment, recommended by the World Health Organization.
  • Growing concerns about antibiotic resistance in Yersinia pestis necessitate exploration of alternative strategies.
  • Various alternative therapies, including immunotherapy and phage therapy, have been investigated.

Conclusions:

  • Alternative therapies for plague warrant comprehensive investigation for clinical application.
  • Addressing antibiotic resistance is crucial for future plague treatment protocols.
  • Continued research into novel Yersinia pestis treatments is essential for public health security.

Related Concept Videos

Plague01:24

Plague

Plague is a highly virulent zoonotic disease caused by Yersinia pestis, a Gram-negative, facultatively anaerobic coccobacillus. This pathogen primarily circulates among rodent populations and is transmitted to humans through the bite of infected fleas. Additional transmission routes include direct contact with infected animal tissue or inhalation of respiratory droplets from individuals with pneumonic plague. These multiple transmission pathways highlight the bacterium’s potential for rapid...
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Antiprotozoal Agents01:21

Antiprotozoal Agents

Leishmaniasis is a widespread parasitic disease caused by several Leishmania species. It affects millions of people each year and remains a major public health problem in endemic regions. First-line treatment relies on pentavalent antimonials, including meglumine antimoniate and sodium stibogluconate. Even so, how these drugs work has not been fully clear, especially their interaction with parasite-specific biochemical pathways. One key target is trypanothione reductase (TR), an enzyme that...
Biological Methods for Microbial Control01:28

Biological Methods for Microbial Control

Biological agents offer an effective means of controlling microbial growth by leveraging natural processes like predation, competition, and the secretion of antimicrobial substances.Predatory bacteria such as Bdellovibrio species target and kill pathogens like Salmonella and E. coli. They are widely used in poultry farms to control infections. Myxococcus species help combat plant-pathogenic fungi. These naturally occurring predators serve as eco-friendly alternatives to chemical pesticides and...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...